Markets head into the final days of September with earnings, macro policy, and short squeezes all converging at once.
Micron is the week's marquee event. Results drop Wednesday after the close. The memory chip maker is up 279% year-to-date. Options traders are split on direction — both bullish and bearish bets rank among the week's highest. That two-sided flow signals real uncertainty. Before that, Carnival and CarMax report today. McCormick and Nike follow later in the week.
Short sellers pressed hard into MiniMed Group this week. SI jumped from 41% to 68.5% of free float in seven days. Availability is nearly gone at just 2.1%. A positive catalyst could trigger a fast unwind. stays deeply shorted at 81.3% of float with zero availability. Meanwhile, saw short interest surge 68% in a single week as tariff uncertainty and KCS integration concerns bite.
Trump unveiled a $15 billion Iowa steel plant today. He credited 50% tariffs for reviving the domestic steel industry. That keeps trade policy front and centre as quarter-end approaches.
Tesla got a fresh geographic win. Croatia approved FSD Supervised, with rollout beginning soon. It is a small market but signals continued regulatory momentum across Europe. On the pharma side, Merck triggered a milestone payment of up to $493 million as partner Cyprumed's oral peptide tablet entered Phase I human trials today.
Analysts lifted targets on Robinhood and Lumentum while trimming Costco and Alexandria Real Estate. The divergence reflects a market that rewards growth names and punishes stretched defensive valuations at quarter-end.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
